POSC209 Cost of Treatment with Biosimilars - Case with Rituximab in Oncohematology
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.724
https://www.valueinhealthjournal.com/article/S1098-3015(21)02519-5/fulltext
Title :
POSC209 Cost of Treatment with Biosimilars - Case with Rituximab in Oncohematology
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02519-5&doi=10.1016/j.jval.2021.11.724
First page :
Section Title :
Open access? :
No
Section Order :
10252